• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Enforcement Report - Week of May 8, 2013

  • Print
  • Share
  • E-mail

Product Detail

Product Description Source Plasma
Recall Number B-1026-13
Classification Class III
Code Info 07IMOG3145;07IMOG3633;07IMOG4399;07IMOG5428; 07IMOG7544;07IMOG8065;07IMOG9727;08IMOA1536; 08IMOA2184;08IMOA3310;08IMOA3940;08IMOA5130; 08IMOA5775;08IMOA6926;08IMOA7545;08IMOA8600; 08IMOA9170;08IMOB0195;08IMOB0120;08IMOB1852; 08IMOB2406;08IMOB3476;08IMOB4110;08IMOB6915; 08IMOB7535;08IMOB8596;08IMOB9162;08IMOC0356; 08IMOC1016;08IMOC2529;08IMOC3217;08IMOC4380; 08IMOC5073;08IMOC6209;08IMOC6880;08IMOC9283; 08IMOC9918;08IMOD1004;08IMOD1628;08IMOD2715; 08IMOD3403
Product Distributed Qty 41 Units
Reason For Recall Blood products, collected from donors for whom donor suitability was not adequately determined, were distributed.

Event Detail

Event Id 49760
Product Type Biologics
Status Terminated
Recalling Firm BioLife Plasma Services LP
City Independence
State MO
Country US
Voluntary / Mandated Voluntary: Firm Initiated
Recall Initiation Date 2008-07-18
Initial Firm Notification of Consignee or Public E-Mail
Distribution Pattern California